相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 update
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2020)
In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs
Zarko Gagic et al.
FRONTIERS IN CHEMISTRY (2020)
Role of Indole Scaffolds as Pharmacophores in the Development of Anti-Lung Cancer Agents
Jyothi Dhuguru et al.
MOLECULES (2020)
Exploring indole derivatives as myeloid cell leukaemia-1 (Mcl-1) inhibitors with multi-QSAR approach: a novel hope in anti-cancer drug discovery
Sk. Abdul Amin et al.
NEW JOURNAL OF CHEMISTRY (2020)
First Report on 3-(3-oxoaryl) Indole Derivatives as Anticancer Agents: Microwave Assisted Synthesis, In Vitro Screening and Molecular Docking Studies
Tarun Patel et al.
CHEMISTRYSELECT (2019)
2-Phenylindole derivatives as anticancer agents: synthesis and screening against murine melanoma, human lung and breast cancer cell lines
Ruchi Gaikwad et al.
SYNTHETIC COMMUNICATIONS (2019)
Design, Synthesis and Biological Evaluation of a Novel Series of Indole-3-Carboxamide Derivatives for Cancer Treatment as EGFR Inhibitors
Lan Zhang et al.
LETTERS IN DRUG DESIGN & DISCOVERY (2018)
Indole in the target-based design of anticancer agents: A versatile scaffold with diverse mechanisms
Sakineh Dadashpour et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Design, synthesis, mechanistic and histopathological studies of small-molecules of novel indole-2-carboxamides and pyrazino[1,2-a]indol-1(2H)-ones as potential anticancer agents effecting the reactive oxygen species production
Bahaa G. M. Youssif et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Mechanisms of receptor tyrosine kinase activation in cancer
Zhenfang Du et al.
MOLECULAR CANCER (2018)
Kinase-targeted cancer therapies: progress, challenges and future directions
Khushwant S. Bhullar et al.
MOLECULAR CANCER (2018)
Kinase inhibitors: the road ahead
Fleur M. Ferguson et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Monte Carlo based modelling approach for designing and predicting cytotoxicity of 2-phenylindole derivatives against breast cancer cell line MCF7
Ruchi Gaikwad et al.
TOXICOLOGY IN VITRO (2018)
The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy
Fatima Ardito et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)
Kinase Inhibitor Indole Derivatives as Anticancer Agents: A Patent Review
Anuj K. Rathi et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2017)
Computer-aided design, synthesis, and biological evaluation of new indole-2-carboxamide derivatives as PI3Kα/EGFR inhibitors
Kamal Sweidan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Discovery of [5-Amino-1-(2-methyl-3H-benzimidazol-5-yl)pyrazol-4-yl]-(1H-indol-2-yl)methanone (CH5183284/Debio 1347), An Orally Available and Selective Fibroblast Growth Factor Receptor (FGFR) Inhibitor
Hirosato Ebiike et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2016)
Ten things you should know about protein kinases: IUPHAR Review 14
Doriano Fabbro et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Design, synthesis and biological evaluation of O-linked indoles as VEGFR-2 kinase inhibitors (I)
Guo-Rui Gao et al.
CHINESE CHEMICAL LETTERS (2015)
NEU3 activity enhances EGFR activation without affecting EGFR expression and acts on its sialylation levels
Alessandra Mozzi et al.
GLYCOBIOLOGY (2015)
Indole Alkaloids from Catharanthus roseus: Bioproduction and Their Effect on Human Health
Lorena Almagro et al.
MOLECULES (2015)
Synthesis and biological activity of 5-chloro-N4-substituted phenyl-9H-pyrimido[4,5-b]indole-2,4-diamines as vascular endothelial growth factor receptor-2 inhibitors and antiangiogenic agents
Aleem Gangjee et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Indolinones as Promising Scaffold as Kinase Inhibitors: A Review
C. R. Prakash et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2012)
Synthesis and Biological Study of Novel Indole-3-Imine-2-on Derivatives as Src Kinase and Glutathione S-Transferase Inhibitors
Z. Kilic Kurt et al.
Letters in Drug Design & Discovery (2012)
Discovery of novel tetracyclic compounds as anaplastic lymphoma kinase inhibitors
Kazutomo Kinoshita et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
KDR inhibitor with the intramolecular non-bonded interaction: Conformation-activity relationships of novel indole-3-carboxamide derivatives
Takahiro Honda et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
3-Substitued indoles: One-pot synthesis and evaluation of anticancer and Src kinase inhibitory activities
V. Kameshwara Rao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Dual IGF-1R/SRC inhibitors based on a N′-aroyl-2-(1H-indol-3-yl)-2-oxoacetohydrazide structure
Stefanie Schmidt et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
9-Substituted 6,6-Dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazoles as Highly Selective and Potent Anaplastic Lymphoma Kinase Inhibitors
Kazutomo Kinoshita et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Anticancer Properties of Indole Compounds: Mechanism of Apoptosis Induction and Role in Chemotherapy
Aamir Ahmad et al.
CURRENT DRUG TARGETS (2010)
Single Agents with Designed Combination Chemotherapy Potential: Synthesis and Evaluation of Substituted Pyrimido[4,5-b]indoles as Receptor Tyrosine Kinase and Thymidylate Synthase Inhibitors and as Antitumor Agents
Aleem Gangjee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Through the Gatekeeper Door: Exploiting the Active Kinase Conformation
Fabio Zuccotto et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
The opposing roles of Wnt-5a in cancer
S. L. McDonald et al.
BRITISH JOURNAL OF CANCER (2009)
Signaling cross-talk between TGF-beta/BMP and other pathways
Xing Guo et al.
CELL RESEARCH (2009)
Wnt/Fz signaling and the cytoskeleton: potential roles in tumorigenesis
Shih-Lei Lai et al.
CELL RESEARCH (2009)
Hedgehog signalling as a target in cancer stem cells
Vanessa Medina et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2009)
Tyrosine Kinase Inhibitors - A Review on Pharmacology, Metabolism and Side Effects
Joerg Thomas Hartmann et al.
CURRENT DRUG METABOLISM (2009)
PI3K and mTOR inhibitors - a new generation of targeted anticancer agents
Saskia Brachmann et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Structural biology contributions to tyrosine kinase drug discovery
Sandra W. Cowan-Jacob et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
PI 3-kinase and cancer: changing accents
Peter K. Vogt et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2009)
Crosstalk of VEGF and Notch pathways in tumour angiogenesis: therapeutic implications
Ji-Liang Li et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Protein kinase C isoforms: Multi-functional regulators of cell life and death
Mary E. Reyland
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
The TGF-beta paradox in human cancer: an update
Maozhen Tian et al.
FUTURE ONCOLOGY (2009)
From Nature to Drug Discovery: The Indole Scaffold as a 'Privileged Structure'
Fernando Rodrigues de Sa Alves et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2009)
Protein kinase Cε: an oncogene and emerging tumor biomarker
Michael A. Gorin et al.
MOLECULAR CANCER (2009)
Recent Developments in Anti-Cancer Agents Targeting the Ras/Raf/MEK/ERK Pathway
Kwong-Kwok Wong
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2009)
Src family kinases: Regulation of their activities, levels and identification of new pathways
Evan Ingley
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2008)
7-[1H-indol-2-yl]-2,3-dihydro-isoindol-1-ones as dual Aurora-A/VEGF-R2 kinase inhibitors:: Design, synthesis, and biological activity
Terry V. Hughes et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises
Timothy A. Yap et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
Syntheses of 4-(indole-3-yl)quinazolines -: A new class of epidermal growth factor receptor tyrosine kinase inhibitors
Anja Lueth et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2008)
Design, synthesis, and biological evaluation of novel 3-aryl-4-(1H-indole-3yl)-1,5-dihydro-2H-pyrrole-2-ones as vascular endothelial growth factor receptor (VEGF-R) inhibitors
Christian Peifer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Cooperative and redundant roles of VEGFR-2 and VEGFR-3 signaling in adult lymphangiogenesis
Jeremy Goldman et al.
FASEB JOURNAL (2007)
VEGF/VEGFR signalling as a target for inhibiting angiogenesis
Alex Kiselyov et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
The role of Src in solid and hematologic malignancies - Development of new-generation Src inhibitors
Ricardo H. Alvarez et al.
CANCER (2006)
Design, synthesis, and biological evaluation of 3,4-diarylmaleimides as angiogenesis inhibitors
C Peifer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Discovery and evaluation of 3-(5-thien-3-ylpyridin-3-yl)-1H-indoles as a novel class of KDR kinase inhibitors
ME Fraley et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Evaluation of indole esters as inhibitors of p60(c-Src) receptor tyrosine kinase and investigation of the inhibition using receptor docking studies
S Olgen et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2003)
The protein kinase complement of the human genome
G Manning et al.
SCIENCE (2002)
Bis(1H-2-indolyl)methanones as a novel class of inhibitors of the platelet-derived growth factor receptor kinase
S Mahboobi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
The role of protein phosphorylation in human health and disease - Delivered on June 30th 2001 at the FEBS Meeting in Lisbon
P Cohen
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
Src inhibitors: drugs for the treatment of osteoporosis, cancer or both?
M Susa et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2000)
The protein tyrosine kinase family of the human genome
DR Robinson et al.
ONCOGENE (2000)
Pyrrolo[3,4-c]-β-carboline-diones as a novel class of inhibitors of the platelet-derived growth factor receptor kinase
S Teller et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2000)
分享论文
